"The Endocrine Society thanks the Subcommittee for the opportunity to submit the following testimony regarding Fiscal Year (FY) 2022 federal appropriations for biomedical research and public health programs. The Endocrine Society is the world's oldest and largest professional organization of endocrinologists representing approximately 18,000 members worldwide. The Society’s membership includes basic and clinical scientists who receive support from the National Institutes of Health (NIH) for research on endocrine diseases that affect millions of Americans, such as diabetes, thyroid disorders, cancer, infertility, aging, obesity and bone disease. Our membership also includes clinicians who depend on new scientific advances to better treat and cure these diseases. The Society is dedicated to promoting excellence in research, education, and clinical practice in the field of endocrinology. The impact of the coronavirus is a compelling illustration of why we must increase funding for the NIH and CDC to protect public health. To support necessary advances in biomedical research to improve health, the Endocrine Society recommends the NIH receive funding of at least $46.1 billion for fiscal year (FY) 2021; to facilitate the translation of these advances to improve public health, the Endocrine Society recommends the Centers for Disease Control and Prevention (CDC) receive funding of at least $10 billion; and to ensure that women have access to appropriate health services, we recommend that the Title X program be funded at $737 million. This request does not reflect emergency supplemental funds or new programs situated in NIH including the Advanced Research Projects Agency for Health proposed by the administration."
Read the Full Testimony
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.